20.04.2010 • NewsLanxessChinaunder construction

Lanxess Expands Capacities for High-Tech Plastics in China

Lanxess said it will expand capacities at its plant for high-tech plastics in Wuxi, China. The German specialty chemicals company will invest in a third production line at the plant, which will increase compounding capacities by nearly 50% and is scheduled to go on stream mid-2011. After the expansion, the plant will have a capacity of approximately 60,000 mt/y.

“This investment will serve the growing demand from Chinese and Asian customers for premium, high-performance engineering plastics, mainly driven by the booming automotive industry,” said Axel C. Heitmann, Lanxess chairman of the board of management. He added that Lanxess was considering further investments in Wuxi in the near future.

Increased domestic consumption and the growing purchasing power of China’s burgeoning middle class are currently supporting the growth path of the Chinese economy. The mega-trends of mobility and urbanization are key pillars of this growth. As segments of the population shift from rural to urban areas, the result is a greater demand for automobiles and modern urban housing. As a result of this rapid development, China is now the world’s largest automotive market with unit sales projected to rise by 8% to more than 14 million vehicles in 2010. This has led to a significant increase in demand for Lanxess engineering plastics and high-performance rubbers.

Company

Logo:

LANXESS Deutschland GmbH

Kennedyplatz 1
50569 Köln
Germany

Company contact







Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.